Cyagen Biosciences vs uBriGene

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/apac-cyagen/ubrigene

Category	Cyagen Biosciences	uBriGene
Listed site	cro	both
Summary	Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical research, with specialized expertise in humanized mice, gene therapy vectors, and disease-specific models across oncology, neurology, and metabolic disorders.	uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing. Headquartered in Maryland with operations across North America and Asia, the company specializes in bridging ATMP concepts from early…
Services	Specialized & Large-Animal Models Preclinical In Vivo Studies Preclinical In Vitro Studies In Vivo Efficacy Models Translational Research Discovery Research	Analytical Method Development & Validation US FDA Regulatory Strategy EU EMA Regulatory Strategy China NMPA Regulatory Strategy Translational Research
Modalities	Biologics (Monoclonal Antibodies) Oligonucleotide Cell Therapy Gene Therapy AAV / Viral Vector Platform	mRNA Cell Therapy Gene Therapy AAV / Viral Vector Platform
Indications	Oncology Immunology Neurology Metabolic Rare Disease Ophthalmology	Oncology
Locations	Headquarters, Santa Clara, California, United States	Headquarters, Maryland, Maryland, USA Boston, Boston, Massachusetts, USA Worcester, Worcester, Massachusetts, USA
Certifications	AAALAC · Identifier: AAALAC-accredited facilities	FDA · Identifier: 20+ INDs filed and accepted EMA · Identifier: 20+ INDs filed and accepted NMPA · Identifier: 20+ INDs filed and accepted
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.